Fidelity Investments
RBOT

Fidelity Investments’s Vicarious Surgical RBOT Stock Holding History

Fidelity Investments’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-86
Closed -$564 – 5469
2025
Q1 		$564 Buy
+86
New +$1.02K ﹤0.01% 5005
2024
Q4 		– Sell
-66
Closed -$375 – 5768
2024
Q3 		$375 Sell
66
-506
-88% -$3.36K ﹤0.01% 4993
2024
Q2 		$3.36K Buy
572
+99
+21% +$886 ﹤0.01% 4635
2024
Q1 		$4.28K Sell
473
-197
-29% -$2.35K ﹤0.01% 4551
2023
Q4 		$7.38K Buy
670
+12
+2% +$134 ﹤0.01% 4336
2023
Q3 		$11.7K Buy
658
+621
+1,678% +$22.6K ﹤0.01% 4047
2023
Q2 		$2.05K Sell
37
-9
-20% -$573 ﹤0.01% 4589
2023
Q1 		$3.14K Buy
46
+31
+207% +$2.41K ﹤0.01% 4510
2022
Q4 		$907 Sell
15
-41
-73% -$3.81K ﹤0.01% 4671
2022
Q3 		$6K Buy
56
+38
+211% +$4.43K ﹤0.01% 4263
2022
Q2 		$2K Buy
+18
New +$2.2K ﹤0.01% 4587

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments's RBOT Position: Q2 2025 in Review

Fidelity Investments sold out of Vicarious Surgical (RBOT) in Q2 2025, closing a stake of 86 shares — an estimated $564 sold.

Fidelity Investments first reported a position in RBOT in Q2 2022 and held it in 11 quarters. The position peaked at $11.7K in Q3 2023. 30 funds tracked by Wall St. Rank hold RBOT as of Q2 2025.

  • Fidelity Investments reported no remaining Vicarious Surgical position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 86 Vicarious Surgical shares in Q2 2025, an estimated $564.
  • Fidelity Investments first reported a position in Vicarious Surgical in Q2 2022 and held it in 11 quarters.
  • Fidelity Investments's Vicarious Surgical position peaked at $11.7K in Q3 2023.
  • 30 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.